Clinical Edge Journal Scan

Ultrasound evaluation of entheses helps discriminate psoriatic arthritis from fibromyalgia


 

Key clinical point: Ultrasound assessment of entheses may help differentiate psoriatic arthritis (PsA) from fibromyalgia syndrome (FMS) as patients with PsA showed more frequent ultrasound changes both in gray scale (GS) and power Doppler (PD) mode than those with FMS.

Major finding: A higher proportion of patients with PsA vs. FMS was detected with ≥1 entheses in GS ( P < .0001 ) and PD ( P = .0033 ) mode, with GS and PD identifying changes in a higher proportion of PsA vs. FMS entheses ( P < .0001 for both). Area under the curve values for GS and PD mode were 0.77 and 0.66, respectively, with 3.5 being the best cutoff GS score to discriminate PsA from FMS (sensitivity, 0.75; specificity, 0.63).

Study details: Findings are from a post hoc analysis of the cross‐sectional ULISSE study including 140 and 51 patients with PsA and FMS, respectively.

Disclosures: This study was funded by AbbVie Srl. Three authors declared being employees and shareholders of AbbVie, and some of the authors declared receiving consultancy fees and research support from several sources.

Source: Marchesoni A et al. J Clin Med. 2021;11(1):180 (Dec 29). Doi: 10.3390/jcm11010180.

Recommended Reading

Spesolimab speeds lesion clearance in generalized pustular psoriasis
MDedge Rheumatology
Case series show no consensus on treatment for palmoplantar pustulosis, generalized pustular psoriasis
MDedge Rheumatology
Proactive infliximab monitoring found best for sustaining control of inflammatory diseases
MDedge Rheumatology
Discontinuing TNF inhibitors may not be required in PsA patients receiving BNT162b2 SARS-CoV-2 vaccine
MDedge Rheumatology
PsA: Upadacitinib shows similar benefits as monotherapy or in combination with nbDMARDs
MDedge Rheumatology
Psoriatic arthritis management should target both clinical and biochemical inflammation
MDedge Rheumatology
Risankizumab shows promise in PsA patients with inadequate response to csDMARDs
MDedge Rheumatology
Dactylitis indicates a more severe disease phenotype in early PsA
MDedge Rheumatology
Younger age at psoriasis diagnosis or severe disease tied to delayed transition from psoriasis to PsA
MDedge Rheumatology
Real-world efficacy and safety of apremilast in patients with psoriatic arthritis
MDedge Rheumatology